Transduodenal Ampullectomy for the Treatment of Early-Stage Ampulla of Vater Cancer
- 363 Downloads
Transduodenal ampullectomy (TDA) is a less invasive procedure than pancreaticoduodenectomy (PD). However, the outcomes of TDA and PD have been compared rarely in early ampullary cancer.
From September 1994 to June 2013, the patients who underwent curative surgery for Tis or T1 ampulla of Vater neoplasm were identified. The patients were divided into two groups according to the types of surgery; TDA group and PD group. The patient characteristics and survival outcomes were retrospectively investigated between the two groups.
Total 137 patients were included in this study. The 18 patients underwent TDA and 119 patients underwent PD for Tis or T1 ampullary cancer. There was no lymph node metastasis in the patients with Tis tumor although 10 of 104 patients had lymph node metastasis in T1 cancer. After a median follow-up of 50 months (range, 6–148), there were no recurrence after TDA for Tis tumor. However, the TDA was associated with higher local recurrence rate than PD in the patients with T1 ampullary cancer on Kaplan–Meier survival analysis (p = 0.007).
The TDA is feasible treatment for Tis ampulla of Vater neoplasm. However, TDA is unsuitable for the treatment of T1 ampulla of Vater cancer.
KeywordsPancreatic Fistula Positive Resection Margin Benign Neoplasm Ampullary Cancer High Local Recurrence Rate
This research was supported by Grants from IN-SUNG Foundation for Medical Research (CB18041).
Compliance with ethical standards
Conflicts of interest
There are no potential and real conflicts of interest relevant to this article.
- 2.Kimura W, Miyata H, Gotoh M et al (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259:773–780. doi: 10.1097/SLA.0000000000000263 CrossRefPubMedGoogle Scholar